Edwards Lifesciences Corp

KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC EW

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

12,583

Value ($000)

1,073

Weight

0.0%

2013 Q4 - 2025 Q4 (21 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	1,073	0.0%	12,583	12/31/2025
2025 Q3	11/13/2025	674	0.0%	8,670	9/30/2025
2025 Q2	8/13/2025	276	0.0%	3,524	6/30/2025
2025 Q1	5/14/2025	213	0.0%	2,941	3/31/2025
2024 Q4	2/21/2025	76	0.0%	1,025	12/31/2024
2024 Q3	11/13/2024	4,181	0.0%	63,360	9/30/2024
2024 Q2	8/13/2024	6,026	0.0%	65,233	6/30/2024
2024 Q1	5/14/2024	6,371	0.0%	66,665	3/31/2024
2023 Q4	2/13/2024	5,263	0.0%	69,021	12/31/2023
2023 Q3	11/13/2023	3,413	0.0%	49,271	9/30/2023
2023 Q2	8/11/2023	4,682	0.0%	49,635	6/30/2023
2023 Q1	5/16/2023	4,166	0.0%	50,354	3/31/2023
2022 Q4	2/14/2023	3,684	0.0%	49,379	12/31/2022
2022 Q3	11/16/2022	4,252	0.0%	51,469	9/30/2022
2022 Q1	5/16/2022	5	0.0%	40	3/31/2022
2020 Q2	8/14/2020	4	0.0%	63	6/30/2020
2020 Q1	5/15/2020	4	0.0%	21	3/31/2020
2019 Q4	2/13/2020	5	0.0%	21	12/31/2019
2014 Q2	8/5/2014	1,414	0.0%	16,472	6/30/2014
2014 Q1	4/30/2014	1,308	0.0%	17,629	3/31/2014
2013 Q4	1/21/2014	1,073	0.0%	16,310	12/31/2013